|
Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia
|
Apr 2016
|
Int J Hematol
|
aplastic anemia
|
|
Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function
|
Apr 2014
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.
|
Sep 2013
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Blood stream infection after stem cell transplantation in children with idiopathic aplastic anemia
|
Apr 2014
|
Biol Blood Marrow Transplant
|
aplastic anemia
|
|
BNIP3L in myelodysplastic syndromes and acute myeloid leukemia: impact on disease outcome and cellular response to decitabine
|
Nov 2016
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
|
Nov 2013
|
Fu B
|
myelodysplastic syndromes (MDS)
|
|
Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes
|
Jan 2014
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
|
Bone marrow mesenchymal stem cells from aplastic anemia patients preserve functional and immune properties and do not contribute to the pathogenesis of the disease
|
Apr 2014
|
Haematologica
|
aplastic anemia
|
|
Bone Marrow Transplantation (BMT) in Myelodysplastic Syndromes: To BMT or Not to BMT--That Is the Question.
|
Jun 2013
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Bone Marrow Transplantation for Acquired Severe Aplastic Anemia
|
Dec 2014
|
Hematol Oncol Clin North Am
|
aplastic anemia
|
